Plastomics is a technology company.
Plastomics has raised $7.0M across 1 funding round.
Plastomics has raised $7.0M in total across 1 funding round.
# Plastomics: High-Level Overview
Plastomics is an agricultural biotechnology company developing a novel chloroplast-based trait delivery platform for crop improvement.[1][2] The company creates biotech crops with enhanced resistance to insects, diseases, and weeds while delivering higher yields by inserting beneficial traits into plant chloroplasts rather than the nucleus.[1][3] Plastomics serves seed companies and agricultural growers by providing a faster, more efficient pathway to develop and commercialize next-generation biotech crops, addressing critical challenges in global food production as demand is projected to increase 50% globally by 2030.[6]
The company is positioned at the intersection of agricultural innovation and sustainability, tackling the growing problem of pest resistance and climate-driven crop challenges while eliminating regulatory concerns around trait outcrossing—a significant barrier to biotech adoption in crops like sorghum, rice, and sunflower.[1][3][6]
# Origin Story
Plastomics was founded by Jeffrey M. Staub, Ph.D., Chief Scientist and Founder, who recognized a fundamental limitation in how biotech traits are currently delivered to crops.[3] The company emerged from research into chloroplast engineering, a biological approach that leverages the plant's natural photosynthetic machinery to express traits more efficiently than traditional nuclear transformation methods.[2]
The company is based in St. Louis, Missouri, operating within BioGenerator Labs at the Donald Danforth Plant Science Center, positioning it at the center of the 39 North Innovation District in America's agricultural heartland.[4] This location provides access to both research infrastructure and the seed industry ecosystem. Early traction came through collaborative partnerships with established biotech companies and seed producers, including a notable collaboration with Evogene's Ag-Seed division to develop novel insect control traits for soybeans using Evogene's AI-discovered candidate genes.[4]
# Core Differentiators
# Role in the Broader Tech Landscape
Plastomics addresses a critical inflection point in agricultural biotechnology. While genetically modified crops have been commercially available for 25 years, trait development remains slow, expensive, and constrained by regulatory concerns around gene flow.[6] Climate change is intensifying pest and disease pressure, while insect populations are developing resistance to existing chemical and biotech solutions—creating urgent demand for new modes of action and faster innovation cycles.[3]
The company's chloroplast technology represents a paradigm shift in how traits are delivered, not just an incremental improvement. By leveraging the plant's own solar engine—the chloroplast—Plastomics sidesteps fundamental limitations of nuclear transformation while simultaneously addressing environmental and regulatory concerns that have prevented biotech adoption in important global crops. This positions the company at the intersection of three powerful trends: climate adaptation, sustainable agriculture, and AI-driven gene discovery (as evidenced by partnerships with AI-enabled biotech firms like Evogene).[4]
The timing is particularly favorable: global food production must increase dramatically by 2030, seed companies face mounting pressure to innovate faster, and regulators are increasingly receptive to technologies that reduce environmental risk.[6] Plastomics' ability to unlock biotech traits for previously inaccessible crops expands the addressable market significantly.
# Quick Take & Future Outlook
Plastomics is solving a genuine bottleneck in agricultural innovation—not by inventing new traits, but by creating a fundamentally better delivery mechanism. The company's partnerships with established biotech firms and seed companies suggest validation of the technology's commercial viability, though regulatory approval and farmer adoption remain critical milestones.
The company's future likely hinges on three factors: successful commercialization of early products (particularly insect control traits in soybean), regulatory approval for cross-pollinating crops like rice and sorghum, and continued partnerships with larger seed companies to scale manufacturing and distribution. If Plastomics can demonstrate that chloroplast-delivered traits perform as promised in field conditions and gain regulatory clearance, the company could fundamentally reshape how the seed industry develops biotech crops—potentially unlocking billions in value by accelerating innovation cycles and opening new crop categories to biotechnology.
The broader implication: Plastomics exemplifies how platform technologies in agriculture can create asymmetric competitive advantages by solving structural problems rather than incremental ones.
Plastomics has raised $7.0M in total across 1 funding round.
Plastomics's investors include 7BC Venture Capital, Aperture Venture Capital, BootstrapLabs, EVE Atlas, Gaingels, Good Growth Capital, Ingeborg Investments, Revolution, Two Sigma Ventures, Anthony Pompliano, Hoda Eydgahi, Sam Palmisano.
Plastomics has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Series A in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2021 | $7.0M Series A | 7BC Venture Capital, Aperture Venture Capital, BootstrapLabs, EVE Atlas, Gaingels, Good Growth Capital, Ingeborg Investments, Revolution, Two Sigma Ventures, Anthony Pompliano, Hoda Eydgahi, Sam Palmisano, Scot Wingo, Thomas Tull, Will Szczerbiak |